# Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

> **NCT01098734** · PHASE2 · COMPLETED · sponsor: **Welichem Biotech Inc.** · enrollment: 148 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** WBI-1001

## Key facts

- **NCT ID:** NCT01098734
- **Lead sponsor:** Welichem Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2011-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098734, "Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01098734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*